Cell lysis is the breakdown of cells caused by viral, osmotic, or enzymatic mechanisms, which compromises the cells' integrity. The technique is commonly used in western and southern blotting for the analysis of lipids, proteins, and other biomolecules to degrade or denature sensitive proteins and DNA. Cell disruption, on the other hand, is the process of breaking open the cell membrane and walls in order to obtain intracellular fluids. The key driving factors for the market growth are, advancements in biopharmaceutical and pharmaceutical industries, increasing prevalence of chronic diseases, rising funding on research activities.
MARKET SCOPE
The "Global Cell Lysis and Disruption Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cell lysis and disruption market with detailed market segmentation by product, technique, cell type, application and end user. The report provides key statistics on the market status of the leading cell lysis and disruption market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
- Based on product the market is segmenetd as, instruments, reagents and kits, enzymes, and consumables.
- Based on technique the market is segmented as, reagent-based, and physical disruption.
- Based on cell type the market is segmented as, mammalian cells, bacterial cells, microbial cells, and plant cells.
- Based on application the market is segmented as, protein isolation, downstream processing, cell organelle isolation, and nucleic acid isolation.
- Based on end user the market is segmented as, academic and research institutes, hospitals and diagnostic labs, cell banks, and pharmaceutical and biotechnology companies.
MARKET DYNAMICS
Drivers:
- Advancements in biopharmaceutical and pharmaceutical industries is the key driver for the market growth.
- Increasing prevalence of chronic diseases, rising funding on research activities.
- Growing emphasis on personalized medicine.
Restraints:
- However, involvement of high cost for cell based research activities along with dearth of skilled professionals.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cell lysis and disruption market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cell lysis and disruption market in these regions.
IMPACT OF COVID-19 ON CELL LYSIS AND DISRUPTION MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
MARKET PLAYERS
The report covers key developments in the cell lysis and disruption market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cell lysis and disruption market are anticipated to lucrative growth opportunities in the future with the rising demand for cell lysis and disruption in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cell lysis and disruption market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Roche Molecular Systems, Inc
- BioVision Inc
- Parr Instrument Company
- Cytiva
- Bio-Rad Laboratories, Inc.
- Miltenyi Biotec
- Claremont BioSolutions, LLC.
- IDEX